Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of “Hold” from Brokerages

Definitive Healthcare Corp. (NASDAQ:DH) has been assigned a consensus rating of “Hold” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a sell rating, three have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $3.9417.

Several research firms have recently issued reports on DH. William Blair upgraded shares of Definitive Healthcare to a “strong-buy” rating in a report on Thursday, November 6th. Morgan Stanley reissued an “underperform” rating and set a $3.50 target price on shares of Definitive Healthcare in a research report on Thursday, December 18th. Weiss Ratings restated a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. Canaccord Genuity Group decreased their price target on shares of Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating for the company in a report on Monday, November 10th. Finally, Wall Street Zen downgraded shares of Definitive Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, December 28th.

Definitive Healthcare Trading Down 0.7%

Definitive Healthcare stock opened at $1.40 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.60 and a current ratio of 1.60. The stock has a market cap of $197.90 million, a PE ratio of -0.84 and a beta of 1.59. The stock has a 50-day moving average of $2.21 and a two-hundred day moving average of $2.89. Definitive Healthcare has a one year low of $1.36 and a one year high of $5.22.

More Definitive Healthcare News

Here are the key news stories impacting Definitive Healthcare this week:

• Positive Sentiment: Cash position strengthened — cash and cash equivalents rose to about $163.6M (up ~55% YoY), providing a larger liquidity buffer. Definitive Healthcare Corp. (DH) stock falls on Q4 2025 Earnings
• Positive Sentiment: Revenue roughly in line with expectations — Q4 revenue was about $61.5M, essentially flat YoY and slightly above some estimates, showing demand stability for the data/analytics business. Definitive Healthcare Q4 2025 Press Release / Slide Deck
• Neutral Sentiment: Company filed full Q4 release, slide deck and hosted a conference call — useful for details on customer trends and cost initiatives; review management commentary for color. Q4 Slide Deck / Conference Call
• Negative Sentiment: Guidance disappointed — Q1 EPS guided to $0.03 (vs. consensus ~$0.05) and FY‑2026 EPS guided to $0.14–0.17 (vs. consensus ~$0.21); revenue guidance of $220M–$226M also trails estimates, a main driver of the downward move. Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025
• Negative Sentiment: Profitability metrics mixed/worse in some reports — one summary shows operating loss widening and a larger net loss / diluted EPS miss (Quiver reports diluted EPS -$0.09 and wider losses), which weighed on sentiment; note some sources reported a $0.06 EPS beat — check the company release and call transcript for reconciliation. Definitive Healthcare Corp. (DH) stock falls on Q4 2025 Earnings
• Negative Sentiment: Institutional selling visible — several large funds reduced or exited positions in Q4 (e.g., Palisade, Goldman, NY State Pension), which can amplify downward pressure near-term. Definitive Healthcare Corp. (DH) stock falls on Q4 2025 Earnings

Institutional Trading of Definitive Healthcare

Several large investors have recently added to or reduced their stakes in the company. State of Alaska Department of Revenue increased its holdings in shares of Definitive Healthcare by 109.3% in the fourth quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after purchasing an additional 5,970 shares during the period. Raymond James Financial Inc. purchased a new stake in Definitive Healthcare in the second quarter valued at approximately $32,000. Schonfeld Strategic Advisors LLC purchased a new stake in Definitive Healthcare in the fourth quarter valued at approximately $35,000. Savant Capital LLC acquired a new position in Definitive Healthcare in the 2nd quarter worth approximately $45,000. Finally, SG Americas Securities LLC purchased a new position in Definitive Healthcare during the 4th quarter worth approximately $46,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.